Novigenix Holds First Closing of $20M Series B Funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Stay updated with breaking news from Liquid Immuno Transcriptomic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Investegate announcements from Novigenix SA, Novigenix Announces Closing of its $20M Series B
Expansion of Biopharma precision solutions in the field of Immuno-OncologyLAUSANNE, SWITZERLAND / ACCESSWIRE / November 16, 2022 / Novigenix SA, a leading data-driven precision medicine biotech that develops